Shed Membrane Particles From T Lymphocytes Impair Endothelial Function and Regulate Endothelial Protein Expression
- 6 April 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (13) , 1653-1659
- https://doi.org/10.1161/01.cir.0000124065.31211.6e
Abstract
Background— Microparticles (MPs) are membrane vesicles with procoagulant and proinflammatory properties released during cell activation. The present study was designed to dissect the effects evoked by T lymphocyte–derived MPs on vascular function. Methods and Results— MPs were produced by treatment of the human lymphoid CEM T cell line with actinomycin D or phytohemagglutinin. Incubation of mouse aortic rings with 30 nmol/L MPs resulted in a time-dependent impairment of acetylcholine-induced relaxation of precontracted vessels, with a maximal reduction after 24 hours. MPs also impaired shear stress–induced dilatation of mouse small mesenteric arteries by affecting the nitric oxide (NO) and prostacyclin but not the endothelium-derived hyperpolarizing factor components of the response. However, neither alteration of calcium signaling in response to agonists nor reduction of cyclooxygenase-1 expression accounted for the impairment of the NO and prostacyclin components of the endothelial response. The effect of MPs was rather because of a decrease in expression of endothelial NO synthase and an overexpression of caveolin-1. Furthermore, lymphocyte-derived MPs from diabetic patients or in vivo circulating MPs from either diabetic or HIV-infected patients reduced endothelial NO synthase expression. Finally, the effects of MPs on endothelial cells were not driven through CD11a/CD18 adhesion molecules or the Fas/FasL pathway. Conclusions— MPs from T cells induce endothelial dysfunction in both conductance and resistance arteries by alteration of NO and prostacyclin pathways. MPs regulate protein expression for endothelial NO synthase and caveolin-1. These data contribute to a better understanding of the deleterious effects of enhanced circulating MPs observed in disorders with cardiovascular or immune complications.Keywords
This publication has 27 references indexed in Scilit:
- Caveolae and Caveolin-1 in Human Term Villous TrophoblastPlacenta, 2003
- Type 1 And Type 2 Diabetic Patients Display Different Patterns of Cellular MicroparticlesDiabetes, 2002
- Shedding of the Matrix Metalloproteinases MMP-2, MMP-9, and MT1-MMP as Membrane Vesicle-Associated Components by Endothelial CellsThe American Journal of Pathology, 2002
- High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cellsAtherosclerosis, 2001
- In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulantJournal of Clinical Investigation, 1999
- Shed Membrane Microparticles With Procoagulant Potential in Human Atherosclerotic PlaquesCirculation, 1999
- Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles.Journal of Clinical Investigation, 1997
- The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection.Journal of Clinical Investigation, 1997
- Mechanical behavior of pressurized in vitro prearteriolar vessels determined with a video systemAnnals of Biomedical Engineering, 1984
- Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.Circulation Research, 1977